Testosterone Propionate: Clinical Trials

14 trials of Testosterone Propionate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 1 recruiting, 1 terminated, 1 unknown. 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 414Completed 10, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1

Follow Testosterone Propionate: new trials by email Literature Review of Testosterone Propionate trials Research Report on Testosterone Propionate

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Biopsy of Prostate, Biospecimen Collection, Magnetic Resonance Imaging - Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8
Phase 4RecruitingRoswell Park Cancer Institute6002025-01-152026-05-14
Patient Satisfaction After Switching to Oral Testosterone Undecanoate
Jatenzo - Testosterone Deficiency
Phase 4CompletedUniversity of Miami412021-06-182023-12-14
Vogelxo(R) ABPM Study in Hypogandal Men
Vogelxo - Hypogonadism, Male
Phase 4CompletedUpsher-Smith Laboratories1222020-08-282024-10-18
A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
Aveed Injectable Product, Fortesta, Testim - Hypogonadism, Hypogonadism, Male
Phase 4CompletedEndo USA Inc., a Keenova Therapeutics Company6732020-06-302025-03-14
Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations
Testosterone Undecanoate, Sesame Oil - Caloric Restriction, Exercise
Phase 4CompletedPennington Biomedical Research Center342019-09-232022-10-07
Xiaflex® Plus Testosterone Treatment Pilot Study Protocol
Xiaflex®, Aveed - Peyronie's Disease (PD)
Phase 4CompletedMen's Health Boston202019-01-142020-12-31
Hormones and Decision Making
testosterone propionate, 0.5% cholorbutanol, saline - Dyssocial Behavior
Phase 4CompletedUniversity of Texas at Austin302015-03-012021-04-29
The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel
Topical Testosterone Solution - Hypogonadism
Phase 4CompletedEli Lilly and Company782013-07-012014-10-27
Testosterone and Pain Sensitivity
Testosterone Gel, Placebo Gel - Low Testosterone, Hypogonadism
Phase 4WithdrawnJohns Hopkins University2012-08-012015-03-31
NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)
Testosterone Undeconate (Nebido, BAY86-5037), Placebo - Hypogonadism
Phase 4TerminatedBayer42010-09-012014-11-05
Metabolic Syndrome Criteria and the Effect of Testosterone Treatment in Young Men With Hypogonadism
Testosteron - Hypogonadism
Phase 4CompletedGulhane School of Medicine3122009-08-012010-07-12
The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups
Testosteron 250mg injection, Testosterone 50mg transdermal application - Secondary Hypogonadism
Phase 4CompletedGulhane School of Medicine1402008-09-012011-10-18
Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy
Testosterone 250mg injection, Testosteron 50 mg transdermal gel - Hypogonadotrophic Hypogonadism
Phase 4CompletedGulhane School of Medicine1302008-08-012014-06-24
Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men
Testim, Strength training, placebo - Hypogonadism, Metabolic Syndrome
Phase 4UnknownOdense University Hospital602008-04-012009-09-21

Conditions studied

Hypogonadism (9)  ·  Eunuchism (2)  ·  Metabolic Syndrome (2)  ·  Motor Activity (2)  ·  Antisocial Personality Disorder (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Pain (1)  ·  Penile Induration (1)  ·  Prostatic Neoplasms (1)

Sponsors

Gulhane School of Medicine (3)  ·  Bayer (1)  ·  Eli Lilly and Company (1)  ·  Endo USA Inc., a Keenova Therapeutics Company (1)  ·  Johns Hopkins University (1)  ·  Men's Health Boston (1)  ·  Odense University Hospital (1)  ·  Pennington Biomedical Research Center (1)  ·  Roswell Park Cancer Institute (1)  ·  University of Miami (1)  ·  University of Texas at Austin (1)  ·  Upsher-Smith Laboratories (1)

Countries

United States (9)  ·  Turkey (Türkiye) (3)  ·  Denmark (1)  ·  Germany (1)

Top investigators

Abraham Morgentaler, MD (1)  ·  Ahmed Aly (1)  ·  David Hernandez (1)  ·  Jennifer C Rood, PhD (1)  ·  Marianne Andersen, Md, phd (1)  ·  Ranjith Ramasamy, MD (1)  ·  Robert A Josephs, PhD (1)

Results publications

PMID 17983892, PMID 23730808, PMID 24089589, PMID 29656500, PMID 32853647, PMID 34278044, PMID 36796647, PMID 36949577, PMID 40279652

NIH funding

2009 (1)